Bassett K

References (4)

Title : Policy-induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia - Fisher_2019_Pharmacoepidemiol.Drug.Saf_28_1067
Author(s) : Fisher A , Carney G , Bassett K , Maclure KM , Dormuth CR
Ref : Pharmacoepidemiol Drug Safety , 28 :1067 , 2019
Abstract :
PubMedSearch : Fisher_2019_Pharmacoepidemiol.Drug.Saf_28_1067
PubMedID: 31267629

Title : Comparison of cholinesterase inhibitor safety in real-world practice - Carney_2019_Alzheimers.Dement.(N.Y)_5_732
Author(s) : Carney G , Bassett K , Wright JM , Maclure M , McGuire N , Dormuth CR
Ref : Alzheimers Dement (N Y) , 5 :732 , 2019
Abstract :
PubMedSearch : Carney_2019_Alzheimers.Dement.(N.Y)_5_732
PubMedID: 31921965

Title : Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching - Fisher_2017_Drugs.Aging_34_221
Author(s) : Fisher A , Carney G , Bassett K , Dormuth CR
Ref : Drugs & Aging , 34 :221 , 2017
Abstract :
PubMedSearch : Fisher_2017_Drugs.Aging_34_221
PubMedID: 28138912

Title : Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation - Fisher_2016_Value.Health_19_688
Author(s) : Fisher A , Carney G , Bassett K , Chappell NL
Ref : Value Health , 19 :688 , 2016
Abstract :
PubMedSearch : Fisher_2016_Value.Health_19_688
PubMedID: 27565287